HomeAARD • NASDAQ
add
Aardvark Therapeutics Inc
Previous close
$3.77
Day range
$3.77 - $4.05
Year range
$3.35 - $17.94
Market cap
82.68M USD
Avg Volume
419.22K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Stock Titan
15 minutes ago
UBS (AMUB) offers 12‑month autocallable notes with 11.20% contingent coupon
0.96%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 18.70M | 97.93% |
Net income | -17.60M | -100.46% |
Net profit margin | — | — |
Earnings per share | -0.81 | — |
EBITDA | -18.69M | -97.99% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 110.03M | 49.37% |
Total assets | 117.18M | 51.19% |
Total liabilities | 10.55M | 95.55% |
Total equity | 106.63M | — |
Shares outstanding | 21.82M | — |
Price to book | 0.77 | — |
Return on assets | -37.35% | — |
Return on capital | -40.66% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -17.60M | -100.46% |
Cash from operations | -16.81M | -117.55% |
Cash from investing | 24.30M | 304.30% |
Cash from financing | 274.00K | 127.02% |
Net change in cash | 7.77M | 137.63% |
Free cash flow | -9.30M | -158.41% |
About
Founded
2017
Website
Employees
40
